1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Insomnia Therapies Market
2.3. Global Insomnia Therapies Market, By Treatment, 2025 (US$ Million)
2.4. Global Insomnia Therapies Market, By Sales Channel, 2025 (US$ Million)
2.5. Global Insomnia Therapies Market, By Distribution Channel, 2025 (US$ Million)
2.6. Global Insomnia Therapies Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Insomnia Therapies Market: Competitive Analysis
3.1. Market Positioning of Key Insomnia Therapies Market Vendors
3.2. Strategies Adopted by Insomnia Therapies Market Vendors
4. Insomnia Therapies Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Insomnia Therapies Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Drugs
5.3.1.1. Benzodiazepines
5.3.1.2. Nonbenzodiazepines
5.3.1.3. Antidepressants
5.3.1.4. Orexin Antagonists
5.3.1.5. Melatonin Antagonists
5.3.1.6. Others
5.3.2. Medical Devices
6. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Prescription
6.3.2. Over-the-Counter (OTC)
7. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Other Distribution Channels
8. North America Insomnia Therapies Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
8.3. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
8.4. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
8.5. Insomnia Therapies Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
8.5.1.1.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
8.5.1.1.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
8.5.1.2.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
8.5.1.2.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
8.5.1.3.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
8.5.1.3.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9. UK and European Union Insomnia Therapies Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.3. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.4. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5. Insomnia Therapies Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.1.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.1.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.2.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.2.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.3.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.3.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.4.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.4.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.5.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.5.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
9.5.1.6.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
9.5.1.6.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10. Asia Pacific Insomnia Therapies Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.3. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.4. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5. Insomnia Therapies Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.1.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.1.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.2.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.2.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.3.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.3.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.4.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.4.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.5.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.5.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
10.5.1.6.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
10.5.1.6.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
11. Latin America Insomnia Therapies Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
11.3. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
11.4. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
11.5. Insomnia Therapies Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
11.5.1.1.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
11.5.1.1.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
11.5.1.2.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
11.5.1.2.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
11.5.1.3.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
11.5.1.3.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
12. Middle East and Africa Insomnia Therapies Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
12.3. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
12.4. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
12.5. Insomnia Therapies Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
12.5.1.1.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
12.5.1.1.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
12.5.1.2.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
12.5.1.2.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Insomnia Therapies Market: By Treatment, 2024-2034, USD (Million)
12.5.1.3.2. Insomnia Therapies Market: By Sales Channel, 2024-2034, USD (Million)
12.5.1.3.3. Insomnia Therapies Market: By Distribution Channel, 2024-2034, USD (Million)
13. Company Profile
13.1. Merck & Co. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Ebb Therapeutics
13.3. Paratek Pharmaceuticals Inc.
13.4. Pfizer Inc.
13.5. Sanofi SA
13.6. Electromedical Products International Inc.
13.7. Takeda Pharmaceutical Company Ltd.
13.8. Teva Pharmaceutical Industries LtdCerêve Inc.
13.9. Mylan N.V.
13.10. Sumitomo Dainippon Pharma Co., Ltd.
13.11. Paratek Pharmaceuticals Inc.
13.12. Others
